Abstract
The type I polyhydroxyalkanoate synthase from Cupriavidus necator was heterologously expressed in Escherichia coli with simultaneous overexpression of chaperone proteins. Compared to expression of synthase alone (14.55 mg liter−1), coexpression with chaperones resulted in the production of larger total quantities of enzyme, including a larger proportion in the soluble fraction. The largest increase was seen when the GroEL/GroES system was coexpressed, resulting in approximately 6-fold-greater enzyme yields (82.37 mg liter−1) than in the absence of coexpressed chaperones. The specific activity of the purified enzyme was unaffected by coexpression with chaperones. Therefore, the increase in yield was attributed to an enhanced soluble fraction of synthase. Chaperones were also coexpressed with a polyhydroxyalkanoate production operon, resulting in the production of polymers with generally reduced molecular weights. This suggests a potential use for chaperones to control the physical properties of the polymer.
INTRODUCTION
Polyhydroxyalkanoates (PHAs) are one of the leading candidates to replace petrochemical plastics in many everyday applications (1). The key enzyme in production of PHAs is polyhydroxyalkanoate synthase (PhaC), as its substrate specificity determines which monomers can be polymerized.
PHA synthases are divided into four groups depending on the number of subunits constituting an active enzyme and on their specificity for monomers of different chain lengths (2). The PHA synthase from Cupriavidus necator has been adopted as the archetype for group I synthases and consequently is very well studied. C. necator was previously called Ralstonia eutropha, and the synthase protein is still widely known as PhaCRe, a convention that is followed here.
As a type I synthase, PhaCRe preferentially catalyzes the polymerization of short-chain (R)-hydroxyalkanoic acids (4 to 6 carbon atoms), particularly (R)-3-hydroxybutyrate-coenzyme A (3HB-CoA) to poly(hydroxybutyrate) (PHB) (3). 3HB-CoA is produced from acetyl-CoA by the sequential action of two enzymes: β-ketothiolase (PhaA) and acetoacetyl-CoA reductase (PhaB). The genes encoding these three enzymes constitute an operon in the genome of C. necator and are sufficient to allow production of PHB up to more than 90% of dry cell weight (DCW) when heterologously expressed in Escherichia coli (2).
Unfortunately, no crystal structure exists for any PHA synthase, because the enzyme tends to form inclusion bodies when overexpressed in a bacterial host or to aggregate during purification. Therefore, the catalytic mechanism is not fully understood, and studies of the enzyme must be carried out with the small quantities that can be produced.
There is interest in developing in vitro PHA production processes (4). This would facilitate the development of continuous production systems, eliminate the costly and environmentally damaging process of PHA recovery from within bacterial cells, allow the polymerization of monomeric units that are not easily produced by bacteria, and extend the range of physical properties of the final product. For in vitro production to be feasible on an industrial scale would require production of far larger quantities of PhaC than is currently possible. Therefore, it is important to improve upon the existing methods for PhaC expression both to assist scientific understanding and for more efficient industrial production.
Inclusion body formation is a well-known phenomenon in heterologous protein production, particularly in E. coli (5). Many methods to combat the problem have been suggested, including reducing the concentration of protein by modulating inducer quantities, expression at reduced temperatures (≤30°C), use of specialized “folding” strains such as E. coli Origami, and in vitro refolding of proteins from isolated inclusion bodies (6, 7). However, these techniques increase the time required to obtain active protein and suffer from drawbacks, including reduced protein yield and high cost.
Despite the difficulties involved with PhaC production, little work on improving the efficiency of the process has been reported. Reduced temperatures (typically 30°C) are often used to prevent inclusion body formation, and addition of a mild nonionic detergent such as 6-O-(N-heptylcarbamoyl)-methyl-alpha-d-glucopyranoside (Hecameg) is essential to prevent agglomeration of the enzyme during and after purification (3). Some attempts have also been made to resolubilize inclusion bodies formed by the type II synthases from Pseudomonas oleovorans using S-Sepharose (8) and from Pseudomonas putida by denaturing with 6 M guanidine hydrochloride, followed by refolding (9).
A widely used technique to aid production of biologically active heterologous proteins is simultaneously to overexpress one or more chaperone proteins, which constitute a diverse family, many of which belong to the group of heat shock proteins and are upregulated when the cell is under stress (7, 10, 11). This has been used with success for many different proteins, particularly eukaryotic or membrane-bound proteins (reviewed in reference 12), although the appropriate expression conditions must usually be determined experimentally on a case-by-case basis.
We report here the results of a study on chaperone-assisted PhaCRe expression and PHA production. Three chaperone systems were chosen for coexpression with PhaCRe: GroEL/GroES (plasmid pGro7), trigger factor (Tf; plasmid pTf16) and DnaK/DnaJ/GrpE (plasmid pKJE7). Additionally, Tf and GroEL/GroES were expressed together (plasmid pG-Tf2), as were GroEL/GroES and DnaK/DnaJ/GrpE (plasmid pG-KJE8). The Tf and DnaK/DnaJ/GrpE systems both bind to hydrophobic residues on nascent proteins, preventing aggregation until other folding steps have completed (13, 14). Poorly folded proteins can be targeted to the GroE complex, composed of a barrel with a hydrophobic core of GroEL and a lid of GroES. Conformational changes in GroEL, driven by ATP, force proteins within the barrel into more compact, properly folded conformations (7).
MATERIALS AND METHODS
Strains, plasmids, and genetic manipulation.
The strains and plasmids used in this study are described in Table 1.
Table 1.
Strains and plasmids used in this study
| Strain or plasmid | Relevant features | Source or reference |
|---|---|---|
| Strains | ||
| E. coli BL21(DE3) | E. coli B F− ompT rB− mB− (λDE3) | Novagen |
| E. coli W3110hnsΔ93 | E. coli K12 F− λ− rph-1 hnsΔ93 INV(rrnD, rrnE) | Chen et al.a |
| Cupriavidus necator H16 | Wild type (ATCC 17699) | ATCC |
| Plasmids | ||
| pET15phaCRe | Expression vector providing N-terminal His6 tag containing phaCRe; T7 promoter; Apr | 15 |
| pASG1phaCRe | Expression vector containing phaCRe with C-terminal His6 tag; tet promoter; Apr | This study |
| pGro7 | Expression vector for GroEL/GroES; araB promoter; Cmr | Clontech |
| pTf16 | Expression vector for Tf; araB promoter; Cmr | Clontech |
| pG-Tf2 | Expression vector for GroEL/GroES/Tf; pzt1 promoter; Cmr | Clontech |
| pKJE7 | Expression vector for DnaK/DnaJ/GrpE; araB promoter; Cmr | Clontech |
| pG-KJE8 | Expression vector for GroEL/GroES with pzt1 promoter; DnaK, DnaJ, GrpE with araB promoter; Cmr | Clontech |
| pTrcphaCAB | Expression vector containing C. necator phaCAB operon; trc promoter; Apr | 16 |
C.-C. Chen, R. Walia, K. J. Mukherjee, and D. K. Summers, submitted for publication.
To construct plasmid pASG1phaCRe, the StarGate cloning system (IBA, Germany) was utilized according to the manufacturer's instructions. The phaCRe gene was amplified by PCR with Phusion DNA polymerase (Fisher Scientific) using 5′-phosphorylated primers to allow blunt-ended ligation into the linearized and dephosphorylated vector pENTRY10. pET15phaCRe was used as the template. The forward primer sequence was AATGGCGACCGGCAAAGGC. The reverse primer sequence was TCCCGTGGTGGTGGTGGTGGTGTGCCTTGGCTTTGACGTATCG. Underlined bases represent partial recombination sites that are not expressed in the protein. Bases in bold type encode the His6 tag. Following verification of gene entry by digestion with XbaI and HindIII, the His6-tagged phaCRe gene was transferred to plasmid pASG-IBAwt1 by recombination to create pASG1phaCRe. The integrity of the new plasmid was verified by Sanger sequencing.
Growth conditions.
For PhaCRe expression, strains were grown in 1-liter Erlenmeyer flasks with 200 ml of Luria-Bertani (LB) medium supplemented with ampicillin (100 μg ml−1) and chloramphenicol (30 μg ml−1) as necessary for plasmid selection. Overnight cultures in LB medium (2 ml) were used for inoculation, and the cultures were then incubated at 37°C while shaking at 250 rpm until the optical density at 600 nm (OD600) was approximately 0.6. At this point, PhaCRe production was induced as described below, and the incubation temperature was reduced to 30°C for a further 6 h. The cells were harvested by centrifugation at 4,000 × g for 15 min, washed once with deionized water, and stored at −80°C with 100,000 U lysozyme and 10 μl protease inhibitor for His-tagged proteins (both from Sigma-Aldrich).
The N-terminally tagged PhaCRe was expressed from the T7 promoter by addition of isopropyl β-d-1-thiogalactopyranoside (IPTG, 1 mM). To accumulate chaperone proteins before beginning PhaCRe expression, each culture was supplemented with arabinose (0.5 mg ml−1) and/or anhydrotetracycline (0.2 μg ml−1) depending on the promoter(s) used. The C-terminally tagged PhaCRe was expressed from the tet promoter, which is also induced by anhydrotetracycline. Therefore, in this case only those chaperones controlled by the araB promoter were induced from inoculation, while PhaCRe and the remaining chaperones were induced by addition of anhydrotetracycline (0.2 μg ml−1) at an OD600 of 0.6.
For PHB production, 200-ml cultures were grown in LB medium supplemented with glucose (20 g liter−1). Ampicillin (100 μg ml−1) and chloramphenicol (30 μg ml−1) were added as required, and both chaperone expression and PHB production were induced at the time of inoculation by addition of IPTG (1 mM), arabinose (0.5 mg ml−1), and, if necessary, anhydrotetracycline (0.2 μg ml−1). Cultures were incubated at either 30 or 37°C with shaking at 250 rpm for 72 h. Cells were harvested by centrifugation at 4,000 × g for 15 min, washed once with deionized water, transferred to preweighed polypropylene tubes, freeze-dried, and then weighed to determine DCW.
Protein purification and analysis. (i) Cobalt affinity purification.
Cells were suspended in lysis buffer (2.65 mM NaH2PO4, 47.35 mM Na2HPO4, 300 mM NaCl, 10 mM imidazole, 5% [vol/vol] glycerol and 0.05% [wt/vol] Hecameg) (pH 8.0) and ruptured by 5 cycles of sonication using a Sonopuls HD2200 sonicator (Bandelin) and MS73 tip, set to a 30-s duration, 10% duty cycle, and 10% power, with 5 min on ice between cycles. Cell debris was removed by centrifugation at 4°C followed by filtration of the supernatant with a cellulose acetate syringe filter with a 0.44-μm pore size. Talon His tag purification resin (Clontech) was used for cobalt affinity protein purification according to the manufacturer's instructions. Lysis buffer was used to equilibrate and wash the column, and purified PhaCRe was eluted using the same buffer containing 100 mM imidazole. Elution fractions containing PhaCRe were combined and concentrated, and the buffer was replaced with storage buffer (2.65 mM NaH2PO4, 47.35 mM Na2HPO4, 5% [vol/vol] glycerol and 0.05% [wt/vol] Hecameg) (pH 8.0) using centrifugal filters with a molecular mass cutoff of 10,000 Da.
(ii) PhaCRe activity assay.
The final protein concentration of each sample was determined by measuring the absorbance at 280 nm (A280) with a Nanodrop spectrophotometer (Fisher Scientific). The molar extinction coefficient was taken to be 162,000 M−1 cm−1 (17). Enzyme activity was determined by measuring the decrease in A236 resulting from the cleavage of the thioester bond with an extinction coefficient of 4,500 M−1 cm−1 (18). The reaction mixture consisted of 50 mM phosphate buffer, 200 μM (dl)-3-hydroxybutyryl-CoA (Sigma-Aldrich), 4 μg PhaCRe, and double-distilled water (ddH2O) with a total volume of 400 μl. One enzyme unit was defined as the amount of enzyme that catalyzed the release of 1 μmol CoA per min.
(iii) Polyacrylamide gel electrophoresis and Western blotting.
The purity of PhaCRe was checked by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). A 20-μl portion of each sample of purified PhaCRe was mixed with 10 μl of 3× SDS-PAGE buffer and incubated at 95°C for 3 min before being loaded onto a 10% polyacrylamide gel in Tris-glycine buffer. The loading volume was adjusted so that 1.22 μg protein was loaded per sample. Gels were stained with PageBlue protein-staining solution (Fermentas).
For Western blotting, 10 ml samples of cell culture were taken prior to harvesting. The cells were recovered by centrifugation and washed once in deionized H2O. The cell pellet was resuspended in 500 μl BugBuster cell lysis buffer (Novagen) with 250 μl of Benzonase nuclease (Sigma-Aldrich) and shaken at room temperature for 30 min. The lysis mixture was centrifuged at 17,000 × g for 30 min at 4°C. The supernatant constituted the soluble protein fraction, and the pellet (the insoluble fraction) was dissolved in 500 μl of 1% (wt/vol) SDS. The proteins were separated by SDS-PAGE, and transferred to a polyvinylidene difluoride (PVDF) membrane using a Trans-Blot semidry blotting system (Bio-Rad). His6-tagged PhaCRe was specifically stained using the HisProbe HRP conjugate kit and metal-enhanced DAB substrate (Fisher Scientific). Densitometry analysis was performed using the gel analysis function of ImageJ (National Institutes of Health).
(iv) Analysis of PHB production.
Approximately 20 mg of dried cells were used for methanolysis to convert PHB into its methyl ester by mixing with 2 ml each of chloroform and methanol-sulfuric acid (85:15 vol/vol) and heating at 100°C for 140 min (19). After addition of 1 ml ddH2O to induce phase separation, the filtered lower chloroform layer was subjected to gas chromatography (GC) analysis (Shimadzu GC 2014), with methyl benzoate (0.05%) as an internal standard, in order to calculate the amount of accumulated PHB.
PHB was extracted from dried cells by stirring with 50 ml chloroform per 100 mg PHB for 72 h. After filtering to remove cell debris, the polymer was precipitated by slowly dropping the chloroform solution into methanol and recovered by a further filtration step. The purified polymer was then redissolved in chloroform at a concentration of 1 mg ml−1 for gel permeation chromatography (GPC) to determine the molecular weight. The GPC analysis was conducted at 40°C using a Shimadzu 10A GPC system with Shodex K-806 M and K-802 columns and a 10A refractive index detector. Chloroform was used as the eluent at a flow rate of 0.8 ml min−1. Polystyrene standards (Mp [peak molecular mass] = 1.3 × 103 to 7.5 × 106) with low polydispersity were used to produce a calibration curve.
RESULTS
Production and purification of PhaCRe.
To test the productivity and activity of PhaCRe, with or without coexpression of chaperone proteins, N-terminally His6-tagged PhaCRe was purified from 200-ml shake flask cultures of E. coli BL21(DE3) containing pET15phaCRe, by cobalt affinity chromatography. It has been reported that modifications to the C terminus of PhaCRe can be introduced without affecting enzyme activity only if the hydrophobic environment surrounding the C terminus is maintained (20). To test whether the coexpression of chaperones could prevent the reduction in PhaCRe activity caused by a C-terminal His6 tag, the experiment was repeated using pASG1phaCRe to express a C-terminally tagged protein.
Growth of each culture was quantified by measuring the average final OD600 (Table 2). If necessary, cultures were diluted 10-fold with LB medium to bring the optical density within the linear range of the spectrophotometer. Growth was not affected by expression of GroEL/GroES (pGro7) or Tf (pTf16), but was substantially reduced by expression of GroEL/GroES/Tf (pG-Tf2), DnaK/DnaJ/GrpE (pKJE7) and GroEL/GroES/DnaK/DnaJ/GrpE (pG-KJE8). Chaperone proteins were efficiently produced at high concentration, as determined by SDS-PAGE analysis (data not shown), and so were assumed to be saturating.
Table 2.
Effect of chaperone co-expression on yields of soluble PhaCRea
| Plasmid content | Chaperone(s) expressed | Final OD600b | Protein recovered (mg liter−1) | Specific productivity (mg liter−1 OD unit−1) |
|---|---|---|---|---|
| pET15phaCRec | ||||
| Alone | 4.77 ± 1.7 | 14.55 ± 6.2 | 3.55 ± 2.7 | |
| +pGro7 | GroEL/GroES | 4.89 ± 1.4 | 44.37 ± 9.4 | 9.99 ± 5.2 |
| +pTf16 | Tf | 4.73 ± 1.2 | 36.14 ± 9.5 | 8.20 ± 4.0 |
| +pG-Tf2 | GroEL/GroES/Tf | 0.74 ± 0.3 | 13.44 ± 5.5 | 23.13 ± 20.1 |
| +pKJE7 | DnaK/DnaJ/GrpE | 1.65 ± 0.5 | 10.10 ± 4.0 | 7.10 ± 4.7 |
| +pG-KJE8 | GroEL/GroES/DnaK/DnaJ/GrpE | 2.00 ± 0.9 | 15.84 ± 5.9 | 8.71 ± 4.6 |
| pASG1phaCRed | ||||
| Alone | 5.17 ± 1.4 | 1.77 ± 1.1 | 0.32 ± 0.1 | |
| +pGro7 | GroEL/GroES | 5.20 ± 0.2 | 13.40 ± 2.3 | 2.57 ± 0.4 |
| +pTf16 | Tf | 4.93 ± 0.3 | 17.67 ± 3.5 | 3.58 ± 0.6 |
| +pG-Tf2 | GroEL/GroES/Tf | 0.48 ± 0.1 | 8.00 ± 4.1 | 16.70 ± 8.7 |
| +pKJE7 | DnaK/DnaJ/GrpE | 1.38 ± 0.8 | 1.68 ± 0.9 | 1.22 ± 0.1 |
| +pG-KJE8 | GroEL/GroES/DnaK/DnaJ/GrpE | 3.49 ± 1.1 | 10.35 ± 6.7 | 2.78 ± 0.9 |
All values are averages for cultures grown in triplicate ± standard deviations.
Optical density was measured at 600 nm immediately before cells were harvested.
N-terminally His6 tagged.
C-terminally His6 tagged.
Table 2 also shows the average amount of soluble PhaCRe recovered per liter of bacterial culture. The N-terminally His6-tagged version of PhaCRe (pET15phaCRe) was recovered in much larger quantities than the C-terminally His6-tagged version (pASG1phaCRe). Within the set of strains expressing the N-terminally His6-tagged version, coexpression with GroEL/GroES and with Tf resulted in approximately 3-fold increases in soluble protein, with 44.37 mg liter−1 and 36.14 mg liter−1, respectively, being recovered, compared to 14.55 mg liter−1 for PhaCRe alone. The other chaperone systems resulted in either a small increase (GroEL/GroES/DnaK/DnaJ/GrpE) or a small decrease (GroEL/GroES/Tf and DnaK/DnaJ/GrpE) compared to the control.
A similar pattern was seen for the set of C-terminally tagged PhaCRe strains. GroEL/GroES (13.40 mg liter−1) and Tf (17.67 mg liter−1) resulted in 8- to 10-fold increases compared to the control (1.77 mg liter−1). GroEL/GroES/Tf and GroEL/GroES/DnaK/DnaJ/GrpE coexpression resulted in 5- to 6-fold increases, to 8.00 mg liter−1 and 10.35 mg liter−1, respectively.
To allow for the differences in final culture density, the specific productivity of PhaCRe (mg protein per liter per OD600 unit) was also calculated (Table 2). This confirms that the production of PhaCRe is far more efficient with an N-terminal His6 tag (3.55 mg liter−1 OD unit−1) than a C-terminal His6 tag (0.32 mg liter−1 OD unit−1). Interestingly, despite causing a serious reduction in growth, coexpression with GroEL/GroES/Tf resulted in by far the largest specific productivity for both N-terminally (23.13 mg liter−1 OD unit−1) and C-terminally (16.70 mg liter−1 OD unit−1) tagged synthase.
A one-step purification protocol was used to reduce sample losses. Therefore, some coeluting proteins remained in the final PhaCRe solutions. To assess the degree of contamination from coeluting proteins, samples (approximately 1.2 μg) of PhaCRe solution from either pET15phaCRe or pASG1phaCRe with or without the coexpression of chaperones were electrophoresed through a 10% polyacrylamide gel (Fig. 1). Individual protein bands were excised and identified by trypsin digestion followed by mass spectrometry to produce a protein fingerprint.
Fig 1.

SDS-PAGE gels stained with Coomassie blue, showing PhaCRe purified by cobalt affinity chromatography after expression in BL21(DE3)/pET15phaCRe (a) or BL21(DE3)/pASG1phaCRe (b) with and without chaperone protein coexpression. Bands were identified by digestion with trypsin followed by mass spectrometry fingerprinting. M, prestained molecular mass markers; lane 1, PhaCRe only; lanes 2 to 6, coexpression from pGro7, pTf16, pG-Tf2, pKJE7, and pG-KJE8, respectively. PhaCRe purities shown in the figure were calculated from densitometry analysis.
The major band in each sample was identified as PhaCRe, which comprised 76 to 90% of the protein in each sample as determined by densitometry using ImageJ software (Fig. 1). Additional bands were observed, particularly in the samples with coexpression of DnaK/DnaJ/GrpE. The most abundant of these was an ∼56-kDa digestion product of PhaCRe (10 to 24% of total protein), which most likely resulted from cleavage of 90 to 100 amino acids from the end of the protein. Low concentrations of the DnaK and DnaJ chaperones were also detected in the samples where they were overexpressed. Two additional proteins, which were identified as a putative ligase and SlyD (a peptidyl-prolyl cis-trans isomerase similar to trigger factor), were detected in samples of PhaCRe expressed from pASG1phaCRe but not in samples from pET15phaCRe. None of the copurified proteins, including the PhaCRe degradation product, are expected to display PHA polymerase activity.
Using estimated absorption coefficients generated by the online ProtParam program (web.expasy.org/protparam), we determined the percentage contribution to the A280 of PhaCRe in each sample (data not shown). Due to the relatively high molecular weight and extinction coefficient of PhaCRe, the coeluted protein contributed disproportionately less to the estimate of protein concentration than PhaCRe. Therefore, while the average purity of PhaCRe (in the case of the C-terminally tagged protein, which contained more coeluted proteins) was 82%, it contributed toward an average of 89% of the absorbance. This indicates that the average error attributed to impurities following a one-step purification procedure is approximately 11%.
Effect of chaperones on PhaCRe solubility.
To find out whether the increased yield of soluble PhaCRe when coexpressed with chaperones was due to a net increase in PhaCRe synthesis or to an increase in the proportion of soluble protein, soluble and insoluble protein fractions from cells containing pET15phaCRe alone or with each of the chaperone systems were compared by SDS-PAGE. Because DnaK (70 kDa), GroEL (60 kDa), and trigger factor (56 kDa) all have sizes similar to that of PhaCRe, they obscured the PhaCRe band on an SDS-PAGE gel. Therefore, the PhaCRe was selectively visualized by Western blotting (Fig. 2). The loading volume in each lane was normalized according to OD600.
Fig 2.

Distribution of PhaCRe between the insoluble (I) and soluble (S) protein fractions. PhaCRe was expressed from BL21(DE3) containing pET15phaCRe on its own or coexpressed with chaperone proteins. The relative densities were calculated using ImageJ software. Density relative to PhaCRe is the ratio of the density of each band to the soluble fraction of PhaCRe alone (bold). Relative densities are the ratios of soluble to insoluble fractions within each sample. pGro7, GroEL/GroES; pTf16, Tf; pG-Tf2, GroEL/GroES/Tf; pKJE7, DnaK/DnaJ/GrpE; pG-KJE8, GroEL/GroES/DnaK/DnaJ/GrpE.
With the exception of protein from cells expressing GroEL/GroES/Tf, which grew very poorly, making recovery of protein difficult, the intensities of the bands for the insoluble fractions were similar (ranging from 1.3 to 2.8 times the intensity of the soluble control). However, the intensity of the bands for the soluble fractions increased when chaperone proteins were coexpressed. The two best-performing systems from the purification experiment, GroEL/GroES and Tf, had 1.6- and 2.0-fold more soluble PhaCRe than the control. However, the relative proportions of PhaCRe in these two strains were 0.57 and 0.80, respectively. This is larger than that of PhaCRe expressed without chaperones (0.4) but smaller than those for the other three strains. This suggests that the other chaperone combinations were more efficient at solubilizing the PhaCRe that they produced but either produced less PhaCRe per cell or resulted in less cell growth.
These values are smaller than the relative increases in soluble protein recovered during protein purification, possibly because antibody binding was inhibited by the large quantities of chaperone proteins present in the Western blots. Therefore, these results should be considered only as a semiquantitative indication of the relative amounts of PhaCRe in each fraction. As such, they suggest that chaperones successfully increased both the total amount of protein produced and its solubility, although substantial amounts of protein remained in the insoluble fraction.
Optimization of inducer concentrations.
The most successful coexpression combination in the initial study was N-terminally tagged PhaCRe with GroEL/GroES, which resulted in a 3-fold increase in soluble protein recovered (Table 2). To investigate whether further increases could be achieved, cultures of BL21(DE3) containing pET15phaCRe and pGro7 were grown as before with 0.1, 0.5, or 1.0 mM IPTG and 0, 0.25, 0.5, 1.0, 2.5, or 5.0 mg ml−1 arabinose. The results are displayed in Table 3.
Table 3.
Optimization of PhaCRe production by varying inducer concentration in BL21(DE3) containing pET15phaCRe and pGro7
| Arabinose concn (mg/ml) | Protein recovery (mg liter−1) at IPTG concn (mM) of: |
Specific productivity (mg liter−1 OD unit−1) at IPTG concn (mM) of: |
||||
|---|---|---|---|---|---|---|
| 0.1 | 0.5 | 1.0 | 0.1 | 0.5 | 1.0 | |
| 0 | 12.71 | 10.43 | 13.89 | 2.93 | 2.35 | 2.67 |
| 0.25 | 51.44 | 49.48 | 49.90 | 10.03 | 10.48 | 8.09 |
| 0.50 | 66.53 | 51.12 | 52.04 | 10.35 | 10.08 | 7.95 |
| 1.00 | 81.65 | 50.33 | 59.89 | 14.49 | 10.16 | 9.90 |
| 2.50 | 78.92 | 58.94 | 66.90 | 14.47 | 12.38 | 11.54 |
| 5.00 | 82.37 | 59.88 | 64.60 | 15.43 | 10.97 | 11.71 |
Lower concentrations of IPTG resulted in larger quantities of PhaCRe, suggesting that gentle induction is necessary to allow time for the protein to fold (Table 3). Increasing the concentration of arabinose also increased PhaCRe production. Consequently, both the largest amount of PhaCRe (82.37 mg liter−1) and the highest specific productivity (15.43 mg liter−1 OD unit−1) were achieved with 0.1 mM IPTG and 5.0 mg ml−1 arabinose. This corresponds to a 5.7-fold increase compared to production from pET15phaC only. Gentle expression of PhaCRe combined with coexpression of large amounts of GroEL/GroES is therefore the best strategy to increase soluble PhaCRe production.
Influence of chaperone coexpression on PhaC activity.
To calculate the specific activity of our PhaCRe preparations, the total yield of PhaCRe protein from each 200-ml culture was calculated from the final volume and concentration of purified protein solution after desalting. Activity assays were performed in triplicate for each sample by measuring the decrease in absorbance at 236 nm, corresponding to the 3HB-CoA thioester bond that is broken during polymerization. Analyses for statistical significance were performed using two-tailed t tests assuming unequal sample variance.
The average specific activity of N-terminally His6-tagged PhaCRe produced without chaperone protein coexpression was 12.1 U mg−1 (Fig. 3). The cultures in which protein recovery was increased showed no significant change in specific activity (P > 0.05). However, the specific activity was significantly reduced (P < 0.01) by coexpression of GroEL/GroES/Tf (9.0 U mg−1) and DnaK/DnaJ/GrpE (8.8 U mg−1). When the specific activity was multiplied by the protein productivity to give the average total yield of enzyme (U liter−1), GroEL/GroES and Tf again resulted in significant (P < 0.01) increases (586.3 and 439.7 U liter−1, respectively) compared to PhaCRe alone (168.7 U liter−1). Only DnaK/DnaJ/GrpE significantly (P < 0.01) decreased the yield (82.4 U liter−1). Thus, the most influential effect of the GroEL/GroES and Tf systems (plasmids pGro7 and pTf16) was to increase the amount of soluble protein produced, rather than increasing its specific activity.
Fig 3.
Average specific activities (hatched bars) and total yield per liter (crosshatched bars) for PhaCRe produced from pET15phaCRe (N-terminal His6 tag) (a) and pASG1phaCRe (C-terminal His6 tag) (b) with and without coexpression of chaperone proteins. Error bars represent the standard deviations of results from cultures grown in triplicate, with three replicates of each assay. Values that are significantly different (P < 0.01) from that for PhaCRe only are indicated by asterisks.
The specific activity of C-terminally tagged PhaCRe (expressed from pASG1phaCRe) was significantly lower (P < 0.01) than that of the N-terminally tagged protein (Fig. 3b), so chaperones were not able to rectify the misfolding of PhaCRe caused by His6 tag addition to the C terminus. Compared to an average specific activity of 1.7 U mg−1 for protein produced in cells containing pASG1phaCRe alone, chaperone coexpression either showed no change (P > 0.05) or resulted in a decrease (P < 0.01). Coexpression with GroEL/GroES or Tf both resulted in average specific activities of 1.7 U mg−1. The other three chaperone combinations all resulted in decreased specific activities, with the smallest being 0.9 U mg−1 for DnaK/DnaJ/GrpE. As seen for the N-terminally His6-tagged PhaCRe, the differences between the yields of purified protein were more important than the variation in specific activity. The greatest yield was 30.2 U liter−1 for Tf coexpression, which represents a 10-fold increase over the yield of 3.0 U liter−1 when PhaCRe was expressed alone. Coexpression with every chaperone combination except DnaK/DnaJ/GrpE resulted in a significant increase (P < 0.01) in protein yield compared to PhaCRe alone.
Effect of chaperones on PHB production.
In E. coli, the molecular weight of PHB varies in inverse proportion to the amount of PhaCRe produced (21). As an initial investigation into the effects of improved PhaCRe production (due to chaperone coexpression) on PHB biosynthesis, E. coli W3110hnsΔ93-1 carrying plasmid pTrcphaCAB alone and equivalent strains carrying each of the five chaperone expression plasmids were grown for 72 h in LB medium supplemented with glucose (20 g liter−1) at either 30 or 37°C. The long culture time was chosen to allow sufficient time for PHB accumulation, even if chaperone coexpression negatively influenced cell growth, as for PhaCRe production.
In every case, growth (determined by measuring DCW) was better at 30°C than at 37°C (Table 4). As seen in the PhaCRe production experiments, chaperone protein coexpression sometimes inhibited bacterial growth, and this was particularly evident when cells contained the pGro7 or pG-Tf2 chaperone expression plasmids.
Table 4.
Production of PHB during overexpression of molecular chaperone proteins
| Temp | Protein(s) expressed | DCW (g liter−1) | PHB content (% DCW) | Mn (106) | Mw (106) | Mw/Mn |
|---|---|---|---|---|---|---|
| 30°C | PhaCAB | |||||
| Alone | 6.37 | 65 | 1.37 | 3.09 | 2.3 | |
| +GroEL/GroES | 2.12 | 27 | 1.29 | 2.78 | 2.2 | |
| +Tf | 6.85 | 63 | 1.07 | 2.18 | 2.0 | |
| +GroEL/GroES/Tf | 2.24 | 3 | NDa | ND | ND | |
| +DnaK/DnaJ/GrpE | 7.47 | 49 | 1.42 | 3.00 | 2.1 | |
| +GroEL/GroES/DnaK/DnaJ/GrpE | 7.76 | 59 | 0.86 | 1.93 | 2.2 | |
| 37°C | PhaCAB | |||||
| Alone | 2.46 | 71 | 2.34 | 4.46 | 1.9 | |
| +GroEL/GroES | 0.93 | 13 | 1.46 | 2.75 | 1.9 | |
| +Tf | 2.06 | 70 | 2.07 | 4.71 | 2.3 | |
| +GroEL/GroES/Tf | 1.08 | 1 | ND | ND | ND | |
| +DnaK/DnaJ/GrpE | 2.20 | 44 | 2.42 | 4.66 | 1.9 | |
| +GroEL/GroES/DnaK/DnaJ/GrpE | 2.53 | 28 | 1.60 | 3.35 | 2.1 |
ND, not determined.
There were large variations in the amount of PHB produced by each culture, both between temperatures and between chaperone expression systems. In the absence of chaperone coexpression, PHB accumulated to 65% DCW at 30°C and to 71% DCW at 37°C. In almost every case, coexpression of chaperone proteins substantially reduced the yield of PHB. The biggest reductions were for GroEL/GroES and GroEL/GroES/Tf, with the smallest yields being for GroEL/GroES/Tf coexpression (3% and 1% at 30 and 37°C, respectively).
The number-averaged molecular weights (Mn) were generally decreased by chaperone coexpression (Table 4). At 30°C, Tf and GroEL/GroES/DnaK/DnaJ/GrpE reduced the Mn of PHB by 21.8% and 37.2%, respectively. At 37°C the largest reductions were with GroEL/GroES and GroEL/GroES/DnaK/DnaJ/GrpE (37.6% and 31.6%). Additionally, Mn for each sample was larger at 37°C than at 30°C. Polydispersities (defined as the ratio of Mw to Mn) were not significantly affected by chaperone protein coexpression. Due to poor growth and low PHB yield, molecular weight data were not gathered for GroEL/GroES/Tf.
DISCUSSION
Chaperone protein coexpression was found to assist in the production of soluble PhaCRe in BL21(DE3). The most significant improvements were seen with the production of N-terminally tagged PhaCRe and chaperone expression was not able to restore reduced activity caused by a C-terminal His6 tag. Coexpression of the GroEL/GroES operon (pGro7) was the most successful strategy, increasing soluble PhaCRe recovery 5.7-fold. Enzyme activity was largely unaffected by chaperone protein coexpression, suggesting that soluble PhaCRe is correctly folded in E. coli. The increase in yield was due to substantial increases in the quantity of soluble, active protein that could be recovered by cobalt affinity chromatography. Therefore, the chaperone proteins assisted the folding of polypeptide chains that would otherwise have accumulated in inclusion bodies or be targeted for protein degradation.
As shown in Fig. 2, considerable quantities of insoluble PhaCRe remained in each strain, although the fraction of soluble protein was increased by coexpressing chaperones. This suggests that chaperone proteins are able to allow greater quantities of PhaCRe to be produced in total, either by increasing production or by reducing the amount of protein that is targeted for protease degradation.
Optimization of the expression strategy resulted in even higher yields of soluble PhaCRe (Table 3). The most successful strategy was to use gentle induction of PhaCRe expression (0.1 mM IPTG) but high-level expression of the GroEL/GroES system (5 mg ml−1 arabinose). This ensures a plentiful supply of chaperones to prevent aggregation and assist folding of each PhaCRe polypeptide as soon as it is produced. Further improvements may be possible by combining chaperone coexpression with other strategies, such as expression at reduced temperature, use of longer culture times, or expression in fermentor cultures.
Reduced bacterial growth, a known side effect of chaperone protein coexpression (7), contributed to the difference in total protein yields between the strains used in this study. Another potential cause of these variations is plasmid instability. We attempted to quantify the magnitude of this effect by plating samples of each culture on antibiotic-free and antibiotic-containing LB agar plates, prior to induction (OD600 = 0.6) and after the 6-h production period, and comparing the number of colonies (data not shown). There was no evidence for plasmid instability prior to induction. However, fewer colonies grew with or without antibiotics following protein production, indicating a loss of colony-forming ability during expression, as suggested by others (22). This is in keeping with the observation that the high specific productivity of strains containing pG-Tf2 appeared to be deleterious to growth and suggests that most cells retain the plasmids during protein accumulation. Modulation of the level of chaperone expression could potentially reduce the negative effects on bacterial growth while maintaining the beneficial effects on protein folding, although this effect was not seen in our optimization experiment.
There were differences between the specific activities of PhaCRe expressed with different chaperone systems. It is likely that much of the difference in specific activities is due to variations in the relative amounts of contaminating proteins in each sample. In particular, coexpression from pKJE7 had a larger number of coeluting proteins than other samples and also had a low specific activity (Fig. 1 and 3). The contaminating proteins were identified as a mixture of chaperones (DnaK/J), SlyD, and degradation products of PhaCRe. Both DnaK and DnaJ, as well as SlyD, are common contaminants of His6 tag-purified proteins due to naturally occurring oligo(His) sequences in their primary structure (23). Therefore, it is not surprising to find traces of them, particularly in a strain overexpressing DnaK and DnaJ proteins.
The specific activity of PhaCRe has previously been reported to be 40 U mg−1, which is substantially higher than the activities reported here (17). The protein preparation in the previous report involved an extra purification step using size exclusion chromatography to remove soluble aggregations of PhaCRe. Although such a procedure would be expected to increase the specific activities in this case (and to reduce variance), absolute specific activity had far less influence on relative yields between cultures than the increase in total soluble protein. Therefore, the conclusions following a one-step purification procedure remain valid.
The C-terminally tagged protein produced from pASG1phaCRe had much lower specific activities than N-terminally tagged protein from pET15phaCRe and was also produced in lower quantities. This suggests that chaperone proteins were not able to rectify the misfolding of PhaCRe caused by the addition of a His6 tag to the C terminus. It is not clear whether the lower quantity of protein was due to differences in the expression signals and/or copy number between the plasmids, increased accumulation in inclusion bodies, or recognition of the badly folded protein and targeting for degradation. However, since chaperone proteins were still able to increase the amount of soluble PhaCRe, it is evident that they play a part in the folding mechanism and are at least partially successful in preventing the aggregation of badly folded protein.
Chaperone protein coexpression generally resulted in a decrease in both the number-averaged and weight-averaged molecular weights of PHB produced in E. coli, particularly for the GroEL/GroES, Tf, and GroEL/GroES/DnaK/DnaJ/GrpE systems. This can be attributed at least in part to the production of a larger number of active PhaCRe molecules. These compete for the available monomeric units and catalyze the production of a larger number of shorter chains than when only the PHB operon is expressed. Consistent with this, pKJE7 caused a small increase in Mn and was also responsible for a reduction in PhaCRe productivity.
Several studies have shown that the addition of exogenous hydroxylated molecules can usefully alter the molecular weights of PHAs generated in vivo. This is thought to occur by transmembrane migration of the agents to assist in chain termination of the polymer (24, 25). Our results point to the use of chaperone-mediated alteration of the monomer-enzyme balance as an alternative route to altering the molecular weight distribution of PHAs. Modulation of PhaC activity has previously been used to vary the molecular weight and yield of PHA produced in E. coli (26) and P. putida (27). Our results agree with the previous finding that PHA molecular weights are inversely related to PhaC activity. While product control by an exogenous agent can be toxicity limited, the expression of the endogenous chaperone could be more flexibly tuned to control the molecular weight of the resulting polymer in order to suit a range of applications.
PHB production relies on an interconnected web of related biochemical pathways, including cellular respiration, which provides the acetyl-CoA that is converted into the monomeric unit for PHB. Since chaperone proteins are actively involved in the folding of the majority of bacterial proteins, it is very likely that overexpression of any of the systems described in this study will simultaneously also affect the levels of the PhaA and PhaB proteins as well as many more diverse native proteins. This hinders a simple interpretation of the results but suggests that the large variations in bacterial growth and PHB accumulation could be due to imbalances in the core biochemical pathways of the cells. Further studies are required to fully understand the mechanism of PHB molecular weight reduction during chaperone coexpression and how this could be translated into a commercially relevant production process.
Chaperone protein coexpression is an effective method for increasing the yield of PhaCRe. By using a widely available set of expression plasmids, this study has demonstrated increases in total enzyme yield of up to 6 times without the need for costly and time-consuming processes such as expression at reduced temperature or in vitro protein refolding. This will facilitate the laboratory-scale study of the enzyme for the purposes of elucidating its structure and catalytic mechanism as well as developing in vitro PHB production methods. The method should also be easily transferrable to the study of other PHA synthases.
ACKNOWLEDGMENT
N.M.T. is funded by the UK Engineering and Physical Sciences Research Council, grant number EP/P504120/1.
Footnotes
Published ahead of print 18 January 2013
REFERENCES
- 1. Sudesh K, Abe H, Doi Y. 2000. Synthesis, structure and properties of polyhydroxyalkanoates: biological polyesters. Prog. Polym. Sci. 25:1503–1555 [Google Scholar]
- 2. Rehm BHA. 2006. Genetics and biochemistry of polyhydroxyalkanoate granule self-assembly: the key role of polyester synthases. Biotechnol. Lett. 28:207–213 [DOI] [PubMed] [Google Scholar]
- 3. Gerngross TU, Snell KD, Peoples OP, Sinskey AJ, Csuhai E, Masamune S, Stubbe J. 1994. Overexpression and purification of the soluble polyhydroxyalkanoate synthase from Alcaligenes eutrophus: evidence for a required posttranslational modification for catalytic activity. Biochemistry 33:9311–9320 [DOI] [PubMed] [Google Scholar]
- 4. Thomson NM, Roy I, Summers DK, Sivaniah E. 2010. In vitro production of polyhydroxyalkanoates: achievements and applications. J. Chem. Technol. Biotechnol. 85:760–767 [Google Scholar]
- 5. Sørensen HP, Mortensen KK. 2005. Soluble expression of recombinant proteins in the cytoplasm of Escherichia coli. Microb. Cell Fact. 4:1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Swartz JR. 2001. Advances in Escherichia coli production of therapeutic proteins. Curr. Opin. Biotechnol. 12:195–201 [DOI] [PubMed] [Google Scholar]
- 7. Thomas JG, Ayling A, Baneyx F. 1997. Molecular chaperones, folding catalysts, and the recovery of active recombinant proteins from E. coli. Appl. Biochem. Biotechnol. 66:197–238 [DOI] [PubMed] [Google Scholar]
- 8. Ren Q, de Roo G, Kessler B, Witholt B. 2000. Recovery of active medium-chain-length-poly-3-hydroxyalkanoate polymerase from inactive inclusion bodies using ion-exchange resin. Biochem. J. 349:599–604 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Rehm BHA, Qi Q, Beermann BB, Hinz HJ, Steinbüchel A. 2001. Matrix-assisted in vitro refolding of Pseudomonas aeruginosa class II polyhydroxyalkanoate synthase from inclusion bodies produced in recombinant Escherichia coli. Biochem. J. 358:263–268 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Baneyx F. 1999. Recombinant protein expression in Escherichia coli. Curr. Opin. Biotechnol. 10:411–421 [DOI] [PubMed] [Google Scholar]
- 11. Young JC, Agashe VR, Siegers K, Hartl FU. 2004. Pathways of chaperone-mediated protein folding in the cytosol. Nat. Rev. Mol. Cell Biol. 5:781–791 [DOI] [PubMed] [Google Scholar]
- 12. Schlieker C, Bukau B, Mogk A. 2002. Prevention and reversion of protein aggregation by molecular chaperones in the E. coli cytosol: implications for their applicability in biotechnology. J. Biotechnol. 96:13–21 [DOI] [PubMed] [Google Scholar]
- 13. Nishihara K, Kanemori M, Yanagi H, Yura T. 2000. Overexpression of trigger factor prevents aggregation of recombinant proteins in Escherichia coli. Appl. Environ. Microbiol. 66:884–889 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Nishihara K, Kanemori M, Kitagawa M, Yanagi H, Yura T. 1998. Chaperone coexpression plasmids: differential and synergistic roles of DnaK-DnaJ-GrpE and GroEL-GroES in assisting folding of an allergen of Japanese cedar pollen, Cryj2, in Escherichia coli. Appl. Environ. Microbiol. 64:1694–1699 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Normi YM, Hiraishi T, Taguchi S, Abe H, Sudesh K, Najimudin N, Doi Y. 2005. Characterization and properties of G4X mutants of Ralstonia eutropha PHA synthase for poly (3-hydroxybutyrate) biosynthesis in Escherichia coli. Macromol. Biosci. 5:197–206 [DOI] [PubMed] [Google Scholar]
- 16. Kahar P, Agus J, Kikkawa Y, Taguchi K, Doi Y, Tsuge T. 2005. Effective production and kinetic characterization of ultra-high-molecular-weight poly [(R)-3-hydroxybutyrate] in recombinant Escherichia coli. Polym. Degrad. Stabil. 87:161–169 [Google Scholar]
- 17. Yuan W, Jia Y, Tian J, Snell KD, Muh U, Sinskey AJ, Lambalot RH, Walsh CT, Stubbe J. 2001. Class I and III polyhydroxyalkanoate synthases from Ralstonia eutropha and Allochromatium vinosum: characterization and substrate specificity studies. Arch. Biochem. Biophys. 394:87–98 [DOI] [PubMed] [Google Scholar]
- 18. Fukui T, Yoshimoto A, Matsumoto M, Hosokawa S, Saito T, Nishikawa H, Tomita K. 1976. Enzymatic synthesis of poly-β-hydroxybutyrate in Zoogloea ramigera. Arch. Microbiol. 110:149–156 [DOI] [PubMed] [Google Scholar]
- 19. Braunegg G, Sonnleitner B, Lafferty RM. 1978. A rapid gas chromatographic method for the determination of poly-β-hydroxybutyric acid in microbial biomass. Appl. Microbiol. Biotechnol. 6:29–37 [Google Scholar]
- 20. Jahns AC, Rehm BHA. 2009. Tolerance of the Ralstonia eutropha class I polyhydroxyalkanoate synthase for translational fusions to its C terminus reveals a new mode of functional display. Appl. Environ. Microbiol. 75:5461–5466 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Agus J, Kahar P, Abe H, Doi Y, Tsuge T. 2006. Molecular weight characterization of poly[(R)-3-hydroxybutyrate] synthesized by genetically engineered strains of Escherichia coli. Polym. Degrad. Stabil. 91:1138–1146 [Google Scholar]
- 22. Yazdani S, Mukherjee KJ. 2002. Continuous-culture studies on the stability and expression of recombinant streptokinase in Escherichia coli. Bioproc. Biosys. Eng. 24:341–346 [Google Scholar]
- 23. Robichon C, Luo J, Causey TB, Benner JS, Samuelson JC. 2011. Engineering Escherichia coli BL21(DE3) derivative strains to minimize E. coli protein contamination after purification by immobilized metal affinity chromatography. Appl. Environ. Microbiol. 77:4634–4646 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Shi F, Ashby RD, Gross RA. 1996. Use of poly(ethylene glycol)s to regulate poly(3-hydroxybutyrate) molecular weight during Alcaligenes eutrophus cultivations. Macromolecules 29:7753–7758 [Google Scholar]
- 25. Tomizawa S, Saito Y, Hyakutake M, Nakamura Y, Abe H, Tsuge T. 2010. Chain transfer reaction catalyzed by various polyhydroxyalkanoate synthases with poly(ethylene glycol) as an exogenous chain transfer agent. Appl. Microbiol. Biotechnol. 87:1427–1435 [DOI] [PubMed] [Google Scholar]
- 26. Sim SJ, Snell KD, Hogan SA, Stubbe J, Rha C, Sinskey AJ. 1997. PHA synthase activity controls the molecular weight and polydispersity of polyhydroxybutyrate in vivo. Nat. Biotechnol. 15:63–67 [DOI] [PubMed] [Google Scholar]
- 27. Ren Q, de Roo G, van Beilen JB, Zinn M, Kessler B, Witholt B. 2005. Poly(3-hydroxyalkanoate) polymerase synthesis and in vitro activity in recombinant Escherichia coli and Pseudomonas putida. Appl. Microbiol. Biotechnol. 69:286–292 [DOI] [PubMed] [Google Scholar]

